Patient Group Direction For the supply and administration of
|
|
- Gladys Watson
- 5 years ago
- Views:
Transcription
1 Patient Group Direction For the supply and administration of Adsorbed low dose DIPHTHERIA/TETANUS/acellular PERTUSSIS/ inactivated POLIO REPEVAX Vaccine (dtap/ipv) Or Adsorbed DIPHTHERIA/TETANUS/acellular PERTUSSIS/ inactivated POLIO INFANRIX-IPV Vaccine(DTaP/IPV) By Registered Nurse/Midwife/Health Visitor To Children aged 3 years 4 months to under 10 years. Valid from 5 th July 2012 Review Date June 2014 Supersedes Infanrix IPV and Repevax IPV template PGD V4September 2010 Developed and Produced by Cheshire and Merseyside Childhood Immunisation PGD subgroup: PCT Professional group Current group member Central & Eastern Cheshire Community Matron Cath Lilley Knowsley Immunisation Co-ordinator Pauline Jones Liverpool V&I training Lead Pauline Morris Liverpool Pharmacist PGD Lead Sue Wright Sefton Pharmaceutical Adviser in Public Health Helen Stubbs Warrington Public Health Consultant Marioth Manche Warrington Immunisation Co-ordinator Tracie Duffy Western Cheshire (Provider Services) Lead Pharmacist John Hickey Wirral CCDC Dr S Ghebrehewet Cheshire & Merseyside HPU Senior Health Protection Nurse Gill Marsh Page 1 of 7
2 1. Characteristics of staff Qualifications required Additional requirements Continued training requirements Registered Nurse / Health Visitor having valid registration with the Nursing and Midwifery Council (NMC). Received training to undertake supply and administration of medicines under Patient Group Directions. Received appropriate training and updates on the administration of immunisations, in accordance with local policy and national HPA guidance, and can demonstrate competence in these areas. Received appropriate training and updates on resuscitation and management of anaphylaxis and demonstrates competence in this area. Annual attendance at update on resuscitation skills and the management of anaphylaxis in the community. Able to provide evidence of continued professional development i.e. meeting Post-Registration Education & Practice (PREP) requirements. 2. Clinical condition or situation Indication Booster vaccination given as part of the routine childhood immunisation programme for active immunisation against diphtheria, tetanus, pertussis and poliomyelitis. Criteria for inclusion All children from 3 years 4 months of age to under 10 years of age. Criteria for exclusion Children under the age of 3yrs and 4months or over 10 years of age A confirmed anaphylactic reaction to a previous dose of vaccine containing the same antigens A confirmed anaphylactic reaction to another component contained in the relevant vaccine. (for previous severe hypersensitivity reactions see special precautions) No Valid Consent. Unstable neurological condition Exclusion under this PGD does not necessarily mean contraindicated Action if excluded Document reason for exclusion Advise when patient may receive vaccine. Immunise as soon as valid consent is obtained. Unstable neurological condition defer immunisation and consider referral to paediatrician or paediatric neurologist Advise regarding risks of diphtheria, tetanus, pertussis, polio disease signs and symptoms Provide information about protective effects of vaccine Seek specialist advice if necessary Review by end June 2014 Page 2 of 7
3 2. Clinical condition or situation (continued) Action if patient Document refusal and action taken in patient s record. declines treatment Advise regarding risks of contracting diphtheria, tetanus, pertussis or polio and disease transmission, signs and symptoms. Information about protective effects of vaccine. Special precautions Current acute febrile illness immunisation should be postponed until recovered Either Repevax or Infanrix-IPV can be used for boosting diphtheria, tetanus pertussis and polio in children age 3 years 4 months to under 10 years. Repevax is not recommended for primary immunisation in children under 10 years of age because it contains lowdose diphtheria. Infanrix-IPV is not recommended for primary immunisation in children under 10 years of age because it contains 3-component acellular pertussis vaccine and not the required 5-component. Patients who are immunosuppressed due to disease, e.g. HIV, Hodgkins or treatment e.g. corticosteroids therapy may not achieve an adequate immune response and may require additional doses - SEEK ADVICE FROM THE APPROPRIATE MEDICAL OFFICER Patients who are immunosuppressed may not be adequately protected against tetanus, despite having been fully immunised. They should be managed as if they were incompletely immunised. References to national/local policies or guidelines NMC (2010) Standards for Medicines Management NMC (2008) Code of Professional Conduct BNF63 March of Product Characteristics Infanrix-IPV (GlaxoSmithKlineUK) 01/2012; Repevax (Sanofi Pasteur MSD) 02/ Immunisation Against Infectious Disease The Green Book relevant updated Chapters to June 2012 Health care professionals are reminded that in some circumstances the recommendations regarding vaccines given in the Green Book chapters may differ from those in the Summary of Product Characteristics (SPC) for a particular vaccine. When this occurs, the recommendations in the Green Book are based on current expert advice received from the JCVI and should be followed. Review by end June 2014 Page 3 of 7
4 3. Description of treatment Name, strength & Infanrix-IPV is adsorbed Diphtheria, Tetanus, acellular formulation of drug Pertussis and inactivated Polio vaccine. Repevax is adsorbed low dose Diphtheria, Tetanus, acellular Pertussis and inactivated Polio vaccine. Both Repevax and Infanrix-IPV are presented as a cloudy white suspension in a prefilled syringe Legal status POM Black Triangle No Dose/Dose range 0.5ml Method/Route The vaccine is a suspension. Shake well before use Intramuscular injection, usually into the deltoid muscle but anterolateral thigh muscle may be used. Individuals with a bleeding disorder may have vaccine by deep subcutaneous injection to reduce risk of bleeding. Frequency of administration Identification & Management of Adverse Reactions Additional Facilities Patient advice Follow up Specific Product Information One dose. Ideally, the dose is given 3 years after completion of the primary course, at age 3 years 4months (or as soon as possible after this age). If the primary course was delayed, and the child is over 3 years 4 months, give the booster dose as soon as 1 year has elapsed from completion of the primary course. Fever, restlessness, irritability, abnormal crying, loss of appetite, drowsiness, local reaction (pain, erythema, induration and oedema) within 4 hrs after vaccination and persisting for 1-2 days. Any adverse events that may be attributable to the vaccine should be documented and reported via yellow card system Immediate access to Adrenaline 1 in 1000 injection Inform of possible side effects and their management. Re-arrange appointment if patient needs to postpone immunisation due to febrile illness or infection. Not applicable Review by end June 2014 Page 4 of 7
5 3. Description of treatment (continued) Records Record fully in Trust clinical record / GP records and as required in parent held records and forward immunisation records to the Child Health Information System (CHIS) / Department. Patient name and date of birth Dose, site and route of injection Antigen(s) given, brand, batch and expiry date of vaccine Date and time given and by whom Consent obtained Stage of immunisation (if appropriate) and if/when next dose is due. State if immunisation was given as scheduled or unscheduled. An indication that the vaccine has been administered under a PGD Advice given Immuniser s signature on appropriate record/ password controlled immunisers record on patient e-records. An electronic or manual record of all individuals receiving immunisation under this PGD should be kept for audit purposes Review by end June 2014 Page 5 of 7
6 4. Authorisations Patient Group Direction Authorisation Lead Doctor Name: Dr Sam Ghebrehewet Position: Unit Director and Consultant in Communicable Disease Control, C&MHPU Lead Pharmacist Name: Helen Stubbs Position: Pharmaceutical Adviser in Public Health, Sefton PCT Lead Nurse Name: Gill Marsh Position: Senior Health Protection Nurse Practitioner, C&MHPU PGD Authorised on Behalf of NHS Wirral by: Governance Lead Name: Dr Phil Jennings Position: Wirral CCG Chair PGD Authorised for use in GP Practice by: Senior Partner (or delegate) for GP employed nurses only Name: Position: Review by end June 2014 Page 6 of 7
7 5. Declaration Practitioner I have read the contents of this Patient Group Direction and will work within this remit. Name Signature Date Employer/ Line Manager I give authorisation for the named Health Care Professional who has signed this PGD to administer those vaccines as prescribed within this direction and in accordance with the current Department of Health guidelines (The Green Book - Immunisation against Infectious Disease, HMSO 2006 and updated chapters). Name Signature Date Review by end June 2014 Page 7 of 7
Patient Group Direction For the supply and administration of
Patient Group Direction For the supply and administration of HAEMOPHILUS INFLUENZAE TYPE B AND MENINGOCOCCAL C CONJUGATE VACCINE (HIB-MenC) MENITORIX Vaccine By Registered Nurse/Midwife/Health Visitor
More informationPatient Group Direction For the supply and administration of
Patient Group Direction For the supply and administration of COMBINED HEPATITIS A AND HEPATITIS B VACCINE TWINRIX PAEDIATRIC For Children aged 1 year to under 16 years TWINRIX ADULT For Adults and Adolescents
More informationPatient Group Direction For the supply and administration of
Patient Group Direction For the supply and administration of Adsorbed low dose DIPHTHERIA/TETANUS/acellular PERTUSSIS/ inactivated POLIO REPEVAX Vaccine (dtap/ipv) By Registered Nurse/Midwife/Health Visitor
More informationPatient Group Direction For the supply and administration of
Patient Group Direction For the supply and administration of Vi Capsular Polysaccharide Typhoid Vaccine(Ty2) Brands TYPHERIX Vaccine TYPHIM Vi Vaccine To adults and/or children over 2 years of age Or Oral
More informationPatient Group Direction
Patient Group Direction For the supply and administration of PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT) PNEUMOVAX II Vaccine By Registered Nurse/Midwife/Health Visitor To Adults and children over
More informationThis document expires on Patient Group Direction No. VI 5
Patient Group Direction (PGD) for The Administration of Combined Adsorbed Diphtheria, Tetanus, Pertussis, (Acellular Component) and Inactivated Poliomyelitis Vaccine (Infanrix-IPV ) to children aged between
More informationPatient Group Direction
This Patient Group Direction (PGD) must only be used by registered health professionals who have been named and authorised by their organisation to practice under it. The most recent and in date final
More informationThis document expires on Patient Group Direction No. VI 7
Patient Group Direction (PGD) for The Administration of Combined low-dose Diphtheria, Tetanus, and Inactivated Polio Vaccine (Revaxis ) to individuals aged over 10 years, by Registered Nurses employed
More informationSAMPLE. PGD reviewed by: Dr Tim Patterson, Chris Faldon, John Maloney, Adrian Mackenzie
Patient Group Direction for the Supply or Administration of combined Diphtheria, Tetanus, acellular Pertussis, inactivated Polio vaccine and Haemophilus type b conjugate Vaccine (Infanrix-IPV-HIB) to children
More informationDirection Number: - NECSAT 2014/014
Patient Group Direction (PGD) for the Administration of COMBINED DIPHTHERIA, TETANUS, ACELLULAR PERTUSSIS AND INACTIVATED POLIOMYELITIS VACCINE (Repevax / Infanrix IPV ) by Registered Professionals to
More informationDocument Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the
Document Details Title Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No 1506-41174 Local Ref (optional) Main points the Active immunisation against infection caused by Hepatitis
More informationSAMPLE. PGD Reviewed by: Chris Faldon, John Maloney, Tim Patterson, Adrian MacKenzie, Claire Stein
Patient Group Direction for the supply or administration of haemophilus influenzae type B and meningococcal conjugate vaccine to children requiring immunisation as part of the national childhood vaccination
More informationGG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation of individuals
More informationDocument Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) Hepatitis B Vaccine (Engerix ) Trust Ref No 1505-41182 Local Ref (optional) Main points the Immunisation against Hepatitis B document covers Who is
More informationCONJUGATE MENINGOCOCCAL (ACWY) VACCINE
Cumbria & Lancashire Vaccine PGD Group ADVISORY INFORMATION FOR USE WITH PATIENT SPECIFIC DIRECTION OR INDIVIDUAL PRESCRIPTION SIGNED BY GP OR NON-MEDICAL PRESCRIBER. CONJUGATE MENINGOCOCCAL (ACWY) VACCINE
More informationThis document expires on Patient Group Direction Number VI 19
Patient Group Direction (PGD) for The Administration of Pneumococcal Polysaccharide Vaccine (PPV, Pneumovax II ) to adults over 65 years and at risk groups aged 2 years and over, by Registered Nurses employed
More informationTHIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
Patient Group Direction for Pneumococcal polysaccharide vaccine VERSION: PNEUMOCOCCAL POLY-2013.1 (Pneumovax II ) Start 1 st May 2013 Expiry 30 th April 2015 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED
More informationCLINICAL CONTENT OF PATIENT GROUP DIRECTION FOR PNEUMOCOCCAL CONJUGATE VACCINE (Prevenar 13 )
Patient Group Direction for Pneumococcal Conjugate Vaccine (Prevenar 13 ) Version: PNEUMOCOCCAL CONJUGATE 2014.1 Start 1 st February 2014 Expiry 31 st January 2017 THIS PATIENT GROUP DIRECTION HAS BEEN
More informationPatient Group Direction (PGD) Number (minor amendment June 2014):
Notice to all staff: The Patient Group Directions (PGDs) for the Hertfordshire and South Midlands Area Team may only be used by members of the healthcare professions named on the title page, and only if
More informationPatient Group Direction Hepatitis A vaccine Version: Hepatitis A 2015 Start Date: 1 st July 2015 Expiry Date:30 th June 2018
Patient Group Direction Hepatitis A vaccine Version: Hepatitis A 2015 Start 1 st July 2015 Expiry 30 th June 2018 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: BLACKPOOL
More informationPatient Group Direction For The Administration Of H1N1 (Swine Flu) vaccine
n Patient Group Direction For The Administration Of H1N1 (Swine Flu) vaccine October 2009 PGD version template-2009.1 Page 1 of 8 Rationale Patient Group Direction For The Administration Of H1N1 (Swine
More informationThis document expires on Patient Group Direction No. VI 11
Patient Group Direction (PGD) for The Administration of Combined Inactivated Hepatitis A & Hepatitis B Vaccine (Twinrix adult, Twinrix paediatric) to Adults and Children over one year by Registered Nurses
More informationClinical Condition Indication:
GG&C PGD ref no: 2012/943 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation of individuals
More informationPatient Group Direction for Combined Hepatitis A & B vaccine Version: Hep A + B Start Date: 1 st January 2014 Expiry Date: 31 st December 2015
Patient Group Direction for Combined Hepatitis A & B vaccine Version: Hep A + B 2014.1 Start 1 st January 2014 Expiry 31 st December 2015 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
More informationPatient Group Direction (PGD) Number :
Notice to all staff: The Patient Group Directions (PGDs) for the Central Midlands Area may only be used by members of the healthcare professions named on the title page, and only if each professional has
More informationGG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Active immunisation against disease
More informationPATIENT GROUP DIRECTION. Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif )
PATIENT GROUP DIRECTION Administration of: Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif ) By: Practice Nurses In: General Practice It is the responsibility of the professional working under
More informationDirection Number: - NECSAT 2014/007
Patient Group Direction (PGD) for the Administration of COMBINED LOW DOSE DIPTHERIA, TETANUS AND INACTIVATED POLIO VACCINE (Td/IPV Revaxis ) by Registered Professionals to Individuals Accessing NHS Services
More informationPatient Group Direction No. VI 17. Kathy Wakefield/Lisa Murray. General Practices & TRFT. Relevant Clinical Lead
T i:1 Patient Group Direction (PGD) for The Administration of Meningococcal Group C Conjugate Vaccine (Meningitec /NeisVac-C /Menjugate Kit ) by Registered Nurses employed or commissioned by NHS Rotherham
More informationPatient Group Direction (PGD) Number :
Notice to all staff: The Patient Group Directions (PGDs) for the Hertfordshire and South Midlands Area Team may only be used by members of the healthcare professions named on the title page, and only if
More informationClinical Condition Indication:
Patient Group Direction ( for Health Care GG&C PGD ref no: 2018/1611 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition
More informationThis Patient Group Direction has been developed/reviewed in accordance with NICE guidance by:- Position of Signatory Name Signed Date
Patient Group Direction Administration of Hepatitis B Vaccine By Registered Nurses employed by GP Practices within Stafford & Surrounds Clinical Commissioning Group This Patient Group Direction has been
More informationUse of Infanrix -IPV+Hib in the infant primary immunisation schedule
Use of Infanrix -IPV+Hib in the infant primary immunisation schedule An update for registered healthcare practitioners July 2014 Quality Education for a Healthier Scotland 1 Acknowledgments Many thanks
More informationDirection Number: - NECSAT 2014/010
Patient Group Direction (PGD) for the Administration of COMBINED DIPHTHERIA, TETANUS, ACELLULAR PERTUSSIS and INACTIVATED POLIO AND HIB VACCINE (DTaP/IPV/Hib PEDIACEL and Infanrix IPV + Hib) by Registered
More informationby registered nurses employed by NHS Hertfordshire or Hertfordshire GP Practices and signatories to the PGD
Notice to all staff: NHS Hertfordshire Patient Group Directions (PGDs) may only be used by members of the healthcare professions named on the title page and only if each professional has individually been
More informationChange history Version number Change details Date Updated for National ACWY programme to be implemented August June 2015.
Patient Group Direction for Conjugate Meningococcal ACWY vaccine Version: MEN ACWY CONJUGATE 2015.1 Start 1 st August 2015 Expiry 31 st July 2018 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING
More informationPATIENT GROUP DIRECTION
Midlands and East (Central Midlands) PATIENT GROUP DIRECTION NHS England Midlands and East (Central Midlands): for use in South Midlands and Hertfordshire Patient Group Direction for the administration
More informationPatient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st May 2014 Expiry Date: 30 th April 2017
Patient Group Direction for Varicella vaccine Version: Varicella 2014.1 Start Date: 1 st May 2014 Expiry Date: 30 th April 2017 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
More informationGG&C PGD ref no: 2018/1603 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2018/1603 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Active immunisation
More informationDirection Number: - NECSAT 2014/017
Patient Group Direction (PGD) for the Administration of HEPATITIS B VACCINE For Infants by Registered Professionals to Individuals Accessing NHS Services in Durham, Darlington, Tees (DDT) and Cumbria,
More informationPatient Group Direction (PGD) Number :
Notice to all staff: The Patient Group Directions (PGDs) for the Hertfordshire and South Midlands Area Team may only be used by members of the healthcare professions named on the title page, and only if
More informationHEPATITIS A + TYPHOID VACCINE
GG&C PGD ref no: 2017/1522 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Indicated for active immunisation
More informationPatient Group Direction for HEPATITIS A AND TYPHOID VACCINE. Version No.: 4/2014. Hitesh Patel Pharmaceutical Adviser, NHS Telford & Wrekin CCG
Document Title: Patient Group Direction for HEPATITIS A AND TYPHOID VACCINE PCT Doc Ref.: Local Doc Ref.: PGD Version No.: 4/2014 Author/Owner: File Reference: Document Overseeing Group: Hitesh Patel Pharmaceutical
More informationCommunity Psychiatric Nurse. Consultant Psychiatrist, Substance Misuse Services
PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF HEPATITIS A VACCINE (HAVRIX MONODOSE VACCINE) BY REGISTERED NURSES WORKING IN THE COMMUNITY SUBSTANCE MISUSE TEAMS Version Number : 2 Patient Group
More informationAdministration of Hepatitis A and B Vaccine
PRACTICE: Ref No: PGD/ONEL/2011/006 Valid from December 2011 Valid to December 2013 Supersedes PGD: Any previous PGD used to administer Twinrix Adult and Paediatric vaccine Professional groups covered
More informationGG&C PGD ref no: 2018/1589 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2018/1589 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Individuals requiring active immunisation
More informationPatient Group Direction for the Administration of Haemophilus Influenzae Type b and Meningococcal C conjugated vaccine (Hib/MenC - Menitorex )
Patient Group Direction for the Administration of Haemophilus Influenzae Type b and Meningococcal C conjugated vaccine (Hib/MenC - Menitorex ) This PGD must be read in conjunction with the core PGD (Reference:
More informationPGD for Td/IPV. Version number: 1.1
Patient Group Direction (PGD) for the Administration of Combined Diphtheria (low dose), Tetanus, and Inactivated Poliomyelitis Vaccine (Td/IPV REVAXIS ) This PGD must be read in conjunction with the core
More informationPrescription only medicines (POMs)
Prescription only medicines (POMs) 2017 Learning objectives Explain the legal framework with which registered health care professionals can administer prescription only medicines Define the role and limitations
More informationPatient Group Direction for Rotavirus vaccine Version: ROTAVIRUS (Rotarix ) Start Date: 1 st July 2013 Expiry Date:30 th June 2015
Patient Group Direction for Rotavirus vaccine Version: ROTAVIRUS-2013. 1 (Rotarix ) Start 1 st July 2013 Expiry 30 th June 2015 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
More informationGG&C PGD ref no: 2017/1427 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2017/1427 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Active immunisation against rotavirus.
More informationpatient group direction
REVAXIS v01 1/12 REVAXIS (DIPHTHERIA, TETANUS AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED, REDUCED ANTIGEN(S) CONTENT)) PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic
More informationPGD No Administration of Human Papillomavirus Vaccine (HPV) Types 6, 11, 16 and 18 - Gardasil - September 2012
Notice to all staff: NHS Hertfordshire Patient Group Directions (PGDs) may only be used by members of the healthcare professions named on the title page and only if each professional has individually been
More informationPatient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st April 2016 Expiry Date: 31 st March 2019
Patient Group Direction for Varicella vaccine Version: Varicella 2016.1 Start Date: 1 st April 2016 Expiry Date: 31 st March 2019 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
More informationPROCEDURE REF NO SABP/EXECUTIVE BOARD/0017
PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 NAME OF PROCEDURE: Medicines Procedure: Patient Group Directions for the Administration of Hepatitis B Vaccine for SABP Drug and Alcohol Teams. PURPOSE OF PROCEDURE:
More informationDocument Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml
Title Document Details Patient Group Direction (PGD) Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Trust Ref No 1445-36348 Local Ref (optional) Main points the document The treatment of
More informationUNSCHEDULED VACCINATION OF CHILDREN AND YOUNG PEOPLE WHO HAVE OUTSTANDING ROUTINE IMMUNISATIONS. Service Specification
UNSCHEDULED VACCINATION OF CHILDREN AND YOUNG PEOPLE WHO HAVE OUTSTANDING ROUTINE IMMUNISATIONS Service Specification National Enhanced Service Specification For The Unscheduled Vaccination Of Children
More informationPATIENT GROUP DIRECTION
Midlands and East (Central Midlands) PATIENT GROUP DIRECTION NHS England Midlands and East (Central Midlands): for use in South Midlands and Hertfordshire Patient Group Direction for the administration
More informationClinical Condition Indication:
GG&C PGD ref no: 2016/1366 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Active immunisation against disease
More informationAdministration of shingles (herpes zoster) vaccine (live) Zostavax. Version 7.0 updated for programme from September 2017 to August 2018
Patient Group Direction template Administration of shingles (herpes zoster) vaccine (live) Zostavax Version 7.0 updated for programme from September 2017 to August 2018 This specimen Patient Group Direction
More informationDirection Number: - NECSAT 2015/001
Patient Group Direction (PGD) for the Administration of HEPATITIS A VACCINES by Registered Professionals to Individuals Accessing NHS Services in Cumbria and North East Sub Region (NHS England North) YOU
More informationabcdefghijklm abcde abc a `ÜáÉÑ=jÉÇáÅ~ä=lÑÑáÅÉê=aáêÉÅíçê~íÉ= HAEMOPHILUS INFLUENZAE TYPE B (HIB) VACCINE FOR YOUNG CHILDREN CATCH-UP PROGRAMME
abcdefghijklm `ÜáÉÑ=jÉÇáÅ~ä=lÑÑáÅÉê=aáêÉÅíçê~íÉ= HAEMOPHILUS INFLUENZAE TYPE B (HIB) VACCINE FOR YOUNG CHILDREN CATCH-UP PROGRAMME This letter explains a Haemophilus influenzae type b (Hib) vaccination
More informationConsultation Group: See relevant page in the PGD. Review Date: October 2017
Patient Group Direction For Supply Of Paracetamol Oral Suspension 120mg/5mL For Prevention Of Post Immunisation Fever Following Administration Of Meningococcal Group B Vaccine (Bexsero ) By Community Pharmacists
More informationPATIENT GROUP DIRECTION. Pandemrix (GSK brand) Pandemic influenza vaccine (H1N1)v (Split virion, inactivated, adjuvanted)
PATIENT GROUP DIRECTION Supply / Administration of: Pandemrix (GSK brand) Pandemic influenza vaccine (H1N1)v (Split virion, inactivated, adjuvanted) By: Nurses, Health Visitors and Pharmacists In: General
More informationDocument Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) Salbutamol Aerosol Inhaler and salbutamol Nebulised Solution Trust Ref No 1569-34313 Local Ref (optional) Main points the document Treatment of acute
More informationDirection Number: - NECSAT 2014/003
Patient Group Direction (PGD) for the Administration of MEASLES, MUMPS AND RUBELLA VACCINE (MMR) by Registered Professionals to Individuals Accessing NHS Services in Durham, Darlington, Tees (DDT) and
More informationVaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for midwives. August 2014
Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for midwives August 2014 Quality Education for a Healthier Scotland 1 Key Message There is a lot
More informationDirection Number: - NECSAT 2015/016
Patient Group Direction (PGD) for the Administration of SHINGLES (Herpes Zoster) VACCINE by Registered Professionals to Individuals Accessing NHS Services in Durham, Darlington, Tees, Cumbria, Northumberland
More informationPATIENT GROUP DIRECTION
Midlands and East (Central Midlands) PATIENT GROUP DIRECTION NHS England Midlands and East (Central Midlands) Patient Group Direction for the administration of Bexsero suspension for injection (Meningococcal
More informationPatient Group Direction (PGD) Number :
Notice to all staff: The Patient Group Directions (PGDs) for the Hertfordshire and South Midlands Area Team may only be used by members of the healthcare professions named on the title page, and only if
More informationNATIONAL PATIENT GROUP DIRECTION FOR SUPPLY OF PARACETAMOL ORAL SUSPENSION
NATIONAL PATIENT GROUP DIRECTION FOR SUPPLY OF PARACETAMOL ORAL SUSPENSION 120 mg/5ml FOR PREVENTION OF POST IMMUNISATION FEVER FOLLOWING ADMINISTRATION OF MENINGOCOCCAL GROUP B VACCINE (BEXSERO ) BY AUTHORISED
More informationDirection Number: - NECSAT 2014/012
Patient Group Direction (PGD) for the Administration of SHINGLES (Herpes Zoster) VACCINE by Registered Professionals to Individuals Accessing NHS Services in Durham, Darlington, Tees (DDT) and Cumbria,
More informationCALDERDALE PRIMARY CARE TRUST
CALDERDALE PRIMARY CARE TRUST PATIENT GROUP DIRECTION FOR THE SUPPLY AND ADMINISTRATION OF MEDICINES BY NON- MEDICAL PERSONNEL Progestogen-only emergency contraception for use in Community Pharmacies APPROVED
More informationDirection Number: - NECSAT 2015/004
Patient Group Direction (PGD) for the Administration of TYPHOID VACCINES (TYPHIM Vi, TYPHERIX and VIVOTIF ) by Registered Professionals to Individuals Accessing NHS Services in Cumbria and North East Sub
More informationPatient Group Directions (PGDs)
Patient Group Directions (PGDs) Document level: Trustwide (TW) Code: MP2 Issue number: 4 Lead executive Authors details Type of document Target audience Document purpose Medical Director Senior Clinical
More informationPATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF COMBINED HEPATITIS A&B VACCINE
PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF COMBINED HEPATITIS A&B VACCINE Valid from: June 2016 Review date: May 2018 Expiry date: June 2018 Developed by Name Job Title Signature Date Senior
More informationPNEUMOCOCCAL VACCINE (Prevenar 13 and Pneumovax II )
Patient Group Direction (PGD) for the Administration of PNEUMOCOCCAL VACCINE (Prevenar 13 and Pneumovax II ) by Registered Professionals to Individuals Accessing NHS Services in Durham, Darlington, Tees
More informationPatient Group Direction for the Administration of Human Papilloma Virus (HPV) Vaccine (Gardasil and Cervarix )
Patient Group Direction for the Administration of Human Papilloma Virus (HPV) Vaccine (Gardasil and Cervarix ) This PGD must be read in conjunction with the core PGD (Reference: NHSE(LR)/PGD/Core PGD for
More informationStaff Immunisation Policy
Policy No: IC05 Version: 8.0 Name of Policy: Staff Immunisation Policy Effective From: 18/08/2015 Date Ratified 15/07/2015 Ratified Infection Prevention & Control Committee Review Date 01/07/2017 Sponsor
More informationPatient Group Direction for Measles, Mumps & Rubella Vaccine. PGD Version No.: 7/2013.
Document Title: Patient Group Direction for Measles, Mumps & Rubella Vaccine Area Team Doc Ref.: PGD Version No.: 7/2013 Doc Ref.: http://www.england.nhs.uk/mids-east/ss-at/immunisations/ Author: Owner:
More informationPATIENT GROUP DIRECTION (PGD)
PHE publications gateway number: 2017015 PATIENT GROUP DIRECTION (PGD) Administration of Hepatitis B recombinant DNA (rdna) vaccine (adsorbed) to individuals who are 15 years of age or over and are on
More informationClinician Responsible for Training and Review: Emergency Department Consultant
Patient Group Direction for the supply and/or administration of Paracetamol Oral Suspension 250mg/5ml (Paracetamol paediatric suspension) to children receiving treatment from NHS Borders services. This
More informationPatient Group Direction for GLUCAGON (Version 02) Valid From 1 October September 2019
Version Control This PGD has been agreed by the following organisations FCMS Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history 31/07/17 V02
More informationConsultation Group: See relevant page in the PGD. Review Date: April Expiry Date: April 2020
Patient Group Direction For The Administration Of Low Dose Diphtheria, Tetanus And Inactivated Poliomyelitis Vaccine dt/ipv (Revaxis ) By Nurses, Midwives, Health Visitors And Pharmacists Working Within
More informationPatient Group Direction for the Administration of Hepatitis A vaccine
Patient Group Direction for the Administration of Hepatitis A vaccine This PGD must be read in conjunction with the core PGD (Reference: NHSE(LR)/PGD/Core PGD for Immunisations), which details information
More informationPATIENT GROUP DIRECTION PROCEDURE
PATIENT GROUP DIRECTION PROCEDURE Date approved 2 October 2015 Version 3 Approved by Yvette Oade, Chief Medical Officer Procedure Lead Clinical Governance Lead - Medicines Management Procedure Author Karen
More informationCamden Clinical Commissioning Group
Locally Commissioned Service Clinical Lead Commissioner Reporting Mechanism/Frequency Payment Frequency Payment Contact Childhood Immunisation Dr Oliver Anglin Camden Clinical Commissioning Group Partially
More informationPatient Group Direction For The Administration Of Rotavirus Vaccine Rotarix By Nurses, Midwives and Health Visitors Working Within.
NHS Grampian Patient Group Direction For The Administration Of Rotavirus Vaccine Rotarix By Nurses, Midwives and Health Visitors Working Within NHS Grampian Lead Author: Consultation Group: Approver: Medicines
More informationDeveloped By Name Signature Date
Patient Group Direction 2155 version 2.0 Administration / Supply of Inhaled Salbutamol in Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Trust Date of Introduction:
More informationVersion Number: 02. Patient Group Direction drawn up by: Jayne Bruce - Deputy Director of Nursing Standards and Safety Sussex
PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF INFLUENZA VACCINE BY REGISTERED NURSES (PEER VACCINATORS) TO STAFF WORKING FOR SUSSEX PARTNERSHIP NHS FOUNDATION TRUST Version Number: 02 Patient
More informationPatient Group Direction For The Pre-Exposure Prophylactic Administration Of Rabies Vaccine By Nurses And Pharmacists Working Within NHS Grampian
NHS Grampian Patient Group Direction For The Pre-Exposure Prophylactic Administration Of Rabies Vaccine By Nurses And Pharmacists Working Within NHS Grampian Lead Author: Consultation Group: Approver:
More informationEnhanced Service Specification. Childhood seasonal influenza vaccination programme 2018/19
Enhanced Service Specification Childhood seasonal influenza vaccination programme 2018/19 Contents Childhood seasonal influenza vaccination programme... 1 Contents... 4 1 Introduction... 5 2 Background...
More informationEnhanced Service Specification. Childhood seasonal influenza vaccination programme 2017/18
Enhanced Service Specification Childhood seasonal influenza vaccination programme 2017/18 2 Enhanced Service Specification Childhood seasonal influenza vaccination programme Version number: 1 First published:
More informationDirection Number: - NECSAT 2017/004
Patient Group Direction (PGD) for the Administration of TYPHOID VACCINES (TYPHIM Vi, TYPHERIX and VIVOTIF ) by Registered Professionals to Individuals Accessing NHS Services in Cumbria and North East Sub
More informationPGD Version No.: 3/
Document Title: Patient Group Direction for Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) - Prevenar 13 ( ) Area Team Doc Ref.: PGD Version No.: 3/2014 NHS Doc Ref.: Author: Owner:
More informationDirection Number: - NECSAT 2016/016
Patient Group Direction (PGD) for the Administration of SHINGLES (Herpes Zoster) VACCINE by Registered Professionals to Individuals Accessing NHS Services in Durham, Darlington, Tees, Cumbria, Northumberland
More informationProtocol for the Administration of Inactivated Influenza Vaccine to. Adults by Registered Nurses via Patient Specific Direction
This document has been reviewed in line with the Policy Alignment Process for Liverpool Community Health NHS Trust Services. It is a valid Mersey Care document, however due to organisational change this
More informationVaccination against shingles for adults aged 70 and 79 years of age Q&A s for healthcare professionals
Vaccination against shingles for adults aged 70 and 79 years of age Q&A s for healthcare professionals Background In 2010, the Joint Committee on Vaccination and Immunisation (JCVI) 1 were asked by the
More information